| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 17 Mar 2025 | 17 Mar 2025 |
| With reference to above subject matter and in pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors the Company at their meeting held today i.e. March 17, 2025 at Registered Office of the Company, inter alia considered the following; 1. Appointment of Mr. Nitin Mehra (DIN: 08142337) as Additional (Executive) Director designated as Executive Director subject to approval of shareholders of the Company in the ensuing General Meeting of the Company. 2. Acceptance of resignation of Mr. Jitender Kumar (DIN: 10057415). | ||
| Board Meeting | 21 Oct 2024 | 16 Oct 2024 |
| Fabino Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2024 inter alia to consider and approve Intimation of Board Meeting for Consideration and Approval of Unaudited Financial Results (standalone and consolidated) for half year ended September 2024. Outcome of Board Meeting & Submission of Unaudited Financial Results for Half Year ended September 30, 2024 (As per BSE Announcement Dated on 21/10/2024) | ||
| Board Meeting | 22 Aug 2024 | 22 Aug 2024 |
| Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and on the recommendation of Nomination and Remuneration committee , the Board of Directors of the Company at their meeting held on August 22, 2024 has inter alia, considered and approved the following business as attached | ||
| Board Meeting | 28 May 2024 | 17 May 2024 |
| Fabino Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 inter alia to consider and approve In pursuant to Regulation 29(1) of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of Fabino Life Sciences Limited is scheduled to be held on Tuesday May 28 2024 at Registered Office of the Company to discuss and approve the Audited Financial Results (standalone and consolidated) for Half Year And Year Ended March 31 2024 thereon and any other business with permission of Chair. In continuation of our letter dated May 17, 2024, pursuant to regulation 33 read with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements ) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in its meeting held on 28th May 2024, inter alia considered and approved as attached. Read less.. In continuation of our letter dated May 17, 2024, pursuant to regulation 33 read with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements ) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in its meeting held on 28th May 2024, inter alia considered and approved as attached. Read less.. (As Per BSE Announcement Dated on 28.05.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
